サマリー

慢性骨髄性白血病治療薬の世界市場 2022-2026 年
Technavioは慢性骨髄性白血病治療薬市場を監視しており、2022-2026年の間に21億4000万ドルの成長が見込まれ、予測期間中にCAGR6.1%で加速しています。当レポートでは、慢性骨髄性白血病治療薬市場の全体分析、市場規模と予測、動向、成長ドライバー、課題、さらに約25のベンダーを網羅したベンダー分析を行っています。
現在の世界市場のシナリオ、最新動向とドライバー、市場全体の環境について最新の分析を提供しています。市場は戦略的提携によって牽引されています。
慢性骨髄性白血病治療薬市場の分析には、製品セグメントと地理的展望が含まれます。
Technavioの慢性骨髄性白血病治療薬市場は、以下のように区分されています。
製品別
- 標的治療薬
- 化学療法
- 免疫療法
地域別状況
- 北米
- 欧州
- アジア
- その他の地域 (ROW)
本調査では、パイプライン分子の出現が、今後数年間の慢性骨髄性白血病治療薬市場の成長を促進する主要な理由の1つであると特定しています。また、診断テストや予測マーカーの開発、再生医療における研究の増加は、市場の大きな需要につながるでしょう。
Technavio社は、複数のソースからのデータを調査、合成、総括する方法で、主要パラメータの分析により、市場の詳細な姿を提示します。慢性骨髄性白血病治療薬市場に関する当レポートは、以下の分野を対象としています。
- 慢性骨髄性白血病治療薬の市場サイジング
- 慢性骨髄性白血病治療薬の市場予測
- 慢性骨髄性白血病治療薬市場の産業分析
Technavioの強力なベンダー分析は、顧客が市場での地位を向上できるように設計されており、これに沿って本レポートでは、慢性骨髄性白血病治療薬市場の主要ベンダー数社の詳細な分析を提供しています。その中には、Amneal Pharmaceuticals Inc、Bristol Myers Squibb Co.KG、Dr. Reddys Laboratories Ltd、F. Hoffmann La Roche Ltd.、Ilyang Pharmaceutical Co.Ltd.、Teva Pharmaceutical Industries Ltd.、Viatris Inc.、Lupin Ltd.、および大塚ホールディングス㈱が含まれています。また、慢性骨髄性白血病治療薬市場の分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が戦略を立て、今後訪れるすべての成長機会を活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報および二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/chronic-myelogenous-leukemia-therapeutics-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細な姿を提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示します。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法および分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Product
o 5.1 Market segments
o Exhibit 24: Chart on Product - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
o 5.2 Comparison by Product
o Exhibit 26: Chart on Comparison by Product
o Exhibit 27: Data Table on Comparison by Product
o 5.3 Targeted therapy - Market size and forecast 2021-2026
o Exhibit 28: Chart on Targeted therapy - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Targeted therapy - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Targeted therapy - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Targeted therapy - Year-over-year growth 2021-2026 (%)
o 5.4 Chemotherapy - Market size and forecast 2021-2026
o Exhibit 32: Chart on Chemotherapy - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Chemotherapy - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Chemotherapy - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Chemotherapy - Year-over-year growth 2021-2026 (%)
o 5.5 Immunotherapy - Market size and forecast 2021-2026
o Exhibit 36: Chart on Immunotherapy - Market size and forecast 2021-2026 ($ million)
o Exhibit 37: Data Table on Immunotherapy - Market size and forecast 2021-2026 ($ million)
o Exhibit 38: Chart on Immunotherapy - Year-over-year growth 2021-2026 (%)
o Exhibit 39: Data Table on Immunotherapy - Year-over-year growth 2021-2026 (%)
o 5.6 Market opportunity by Product
o Exhibit 40: Market opportunity by Product ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 44: Chart on Geographic comparison
o Exhibit 45: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Germany - Market size and forecast 2021-2026
o Exhibit 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.9 UK - Market size and forecast 2021-2026
o Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.10 China - Market size and forecast 2021-2026
o Exhibit 74: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.11 Canada - Market size and forecast 2021-2026
o Exhibit 78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 80: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 82: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 83: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 85: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 86: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 87: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 88: Matrix on vendor position and classification
o 10.3 Bristol Myers Squibb Co.
o Exhibit 89: Bristol Myers Squibb Co. - Overview
o Exhibit 90: Bristol Myers Squibb Co. - Product / Service
o Exhibit 91: Bristol Myers Squibb Co. - Key offerings
o 10.4 C. H. Boehringer Sohn AG and Co. KG
o Exhibit 92: C. H. Boehringer Sohn AG and Co. KG - Overview
o Exhibit 93: C. H. Boehringer Sohn AG and Co. KG - Business segments
o Exhibit 94: C. H. Boehringer Sohn AG and Co. KG - Key news
o Exhibit 95: C. H. Boehringer Sohn AG and Co. KG - Key offerings
o Exhibit 96: C. H. Boehringer Sohn AG and Co. KG - Segment focus
o 10.5 Merck KGaA
o Exhibit 97: Merck KGaA - Overview
o Exhibit 98: Merck KGaA - Business segments
o Exhibit 99: Merck KGaA - Key news
o Exhibit 100: Merck KGaA - Key offerings
o Exhibit 101: Merck KGaA - Segment focus
o 10.6 Novartis AG
o Exhibit 102: Novartis AG - Overview
o Exhibit 103: Novartis AG - Business segments
o Exhibit 104: Novartis AG - Key offerings
o Exhibit 105: Novartis AG - Segment focus
o 10.7 Otsuka Holdings Co Ltd
o Exhibit 106: Otsuka Holdings Co Ltd - Overview
o Exhibit 107: Otsuka Holdings Co Ltd - Business segments
o Exhibit 108: Otsuka Holdings Co Ltd - Key offerings
o Exhibit 109: Otsuka Holdings Co Ltd - Segment focus
o 10.8 Pfizer Inc.
o Exhibit 110: Pfizer Inc. - Overview
o Exhibit 111: Pfizer Inc. - Product / Service
o Exhibit 112: Pfizer Inc. - Key news
o Exhibit 113: Pfizer Inc. - Key offerings
o 10.9 Sun Pharmaceutical Industries Ltd
o Exhibit 114: Sun Pharmaceutical Industries Ltd - Overview
o Exhibit 115: Sun Pharmaceutical Industries Ltd - Product / Service
o Exhibit 116: Sun Pharmaceutical Industries Ltd - Key offerings
o 10.10 Takeda Pharmaceutical Co. Ltd.
o Exhibit 117: Takeda Pharmaceutical Co. Ltd. - Overview
o Exhibit 118: Takeda Pharmaceutical Co. Ltd. - Product / Service
o Exhibit 119: Takeda Pharmaceutical Co. Ltd. - Key news
o Exhibit 120: Takeda Pharmaceutical Co. Ltd. - Key offerings
o 10.11 Teva Pharmaceutical Industries Ltd.
o Exhibit 121: Teva Pharmaceutical Industries Ltd. - Overview
o Exhibit 122: Teva Pharmaceutical Industries Ltd. - Business segments
o Exhibit 123: Teva Pharmaceutical Industries Ltd. - Key news
o Exhibit 124: Teva Pharmaceutical Industries Ltd. - Key offerings
o Exhibit 125: Teva Pharmaceutical Industries Ltd. - Segment focus
o 10.12 Viatris Inc.
o Exhibit 126: Viatris Inc. - Overview
o Exhibit 127: Viatris Inc. - Business segments
o Exhibit 128: Viatris Inc. - Key offerings
o Exhibit 129: Viatris Inc. - Segment focus
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 130: Inclusions checklist
o Exhibit 131: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 132: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 133: Research methodology
o Exhibit 134: Validation techniques employed for market sizing
o Exhibit 135: Information sources
o 11.5 List of abbreviations
o Exhibit 136: List of abbreviations
o health: Includes veterinary drugs (excluded from the scope of the report)


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Product - Market share 2021-2026 (%)
Exhibits25: Data Table on Product - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Product
Exhibits27: Data Table on Comparison by Product
Exhibits28: Chart on Targeted therapy - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Targeted therapy - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Targeted therapy - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Targeted therapy - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Chemotherapy - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Chemotherapy - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Chemotherapy - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Chemotherapy - Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Immunotherapy - Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Immunotherapy - Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Immunotherapy - Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Immunotherapy - Year-over-year growth 2021-2026 (%)
Exhibits40: Market opportunity by Product ($ million)
Exhibits41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits44: Chart on Geographic comparison
Exhibits45: Data Table on Geographic comparison
Exhibits46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits82: Market opportunity By Geographical Landscape ($ million)
Exhibits83: Impact of drivers and challenges in 2021 and 2026
Exhibits84: Overview on Criticality of inputs and Factors of differentiation
Exhibits85: Overview on factors of disruption
Exhibits86: Impact of key risks on business
Exhibits87: Vendors covered
Exhibits88: Matrix on vendor position and classification
Exhibits89: Bristol Myers Squibb Co. - Overview
Exhibits90: Bristol Myers Squibb Co. - Product / Service
Exhibits91: Bristol Myers Squibb Co. - Key offerings
Exhibits92: C. H. Boehringer Sohn AG and Co. KG - Overview
Exhibits93: C. H. Boehringer Sohn AG and Co. KG - Business segments
Exhibits94: C. H. Boehringer Sohn AG and Co. KG - Key news
Exhibits95: C. H. Boehringer Sohn AG and Co. KG - Key offerings
Exhibits96: C. H. Boehringer Sohn AG and Co. KG - Segment focus
Exhibits97: Merck KGaA - Overview
Exhibits98: Merck KGaA - Business segments
Exhibits99: Merck KGaA - Key news
Exhibits100: Merck KGaA - Key offerings
Exhibits101: Merck KGaA - Segment focus
Exhibits102: Novartis AG - Overview
Exhibits103: Novartis AG - Business segments
Exhibits104: Novartis AG - Key offerings
Exhibits105: Novartis AG - Segment focus
Exhibits106: Otsuka Holdings Co Ltd - Overview
Exhibits107: Otsuka Holdings Co Ltd - Business segments
Exhibits108: Otsuka Holdings Co Ltd - Key offerings
Exhibits109: Otsuka Holdings Co Ltd - Segment focus
Exhibits110: Pfizer Inc. - Overview
Exhibits111: Pfizer Inc. - Product / Service
Exhibits112: Pfizer Inc. - Key news
Exhibits113: Pfizer Inc. - Key offerings
Exhibits114: Sun Pharmaceutical Industries Ltd - Overview
Exhibits115: Sun Pharmaceutical Industries Ltd - Product / Service
Exhibits116: Sun Pharmaceutical Industries Ltd - Key offerings
Exhibits117: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits118: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits119: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits120: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits121: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits122: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits123: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits124: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits125: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits126: Viatris Inc. - Overview
Exhibits127: Viatris Inc. - Business segments
Exhibits128: Viatris Inc. - Key offerings
Exhibits129: Viatris Inc. - Segment focus
Exhibits130: Inclusions checklist
Exhibits131: Exclusions checklist
Exhibits132: Currency conversion rates for US$
Exhibits133: Research methodology
Exhibits134: Validation techniques employed for market sizing
Exhibits135: Information sources
Exhibits136: List of abbreviations